Récepteur du facteur de croissance des fibroblastes (FGFR)
Les inhibiteurs des récepteurs du facteur de croissance des fibroblastes (FGFR) sont des thérapies ciblées qui bloquent l'activité des FGFR, impliqués dans la prolifération cellulaire, la différenciation et l'angiogenèse. La signalisation FGFR contribue à la formation de nouveaux vaisseaux sanguins dans les tumeurs, favorisant leur croissance et leur survie. Inhiber les FGFR peut donc réduire l'angiogenèse et la progression tumorale. Chez CymitQuimica, nous offrons une gamme d'inhibiteurs de FGFR de haute qualité pour soutenir vos recherches en cancérologie, biologie du développement et angiogenèse.
Produits appartenant à la catégorie "Récepteur du facteur de croissance des fibroblastes (FGFR)"
Trier par
Recifercept
CAS :Recifercept (TA-46) is a recombinant human soluble fibroblast growth factor receptor 3, a decoy protein that competes for ligands of mutant FGFR3.Couleur et forme :LiquidFGFR-IN-11
CAS :FGFR-IN-11 (compound I-5) is an orally active, covalent inhibitor of FGFR, exhibiting IC50 values of 9.9 nM (FGFR1), 3.1 nM (FGFR2), 16 nM (FGFR3), and 1.8 nM (Formule :C28H29ClN4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :521.01FGFR1 inhibitor-8
FGFR1 inhibitor-8 (Compound 9), an FGFR1 inhibitor with an IC50 of 0.5 nM, binds to the ATP-binding pocket of FGFR1 and exhibits anticancer activity [1].Formule :C26H18ClNO5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :459.88BLU9931
CAS :BLU9931 is the first selective small molecule inhibitor of FGFR4.Formule :C26H22Cl2N4O3Degré de pureté :96.958% - 99.85%Couleur et forme :SolidMasse moléculaire :509.38Regorafenib
CAS :Formule :C21H15ClF4N4O3Degré de pureté :>98.0%(HPLC)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :482.82FGFR4-IN-4
CAS :FGFR4-IN-4 is a FGFR4 inhibitor with anti-tumor activity.Formule :C28H32Cl2N6O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :603.5EOC317
CAS :EOC317 (ACTB-1003) is an oral kinase inhibitor (IC50: 6/2/4 nM, for FGFR1/VEGFR2/Tie-2).Formule :C27H26F5N7O3Degré de pureté :98.00% - 99.26%Couleur et forme :SolidMasse moléculaire :591.53Ref: TM-T4318
1mg117,00€2mg172,00€5mg248,00€10mg418,00€25mgÀ demander50mgÀ demander100mgÀ demander1mL*10mM (DMSO)324,00€Nintedanib
CAS :Nintedanib (Intedanib) is a triple vascular kinase inhibitor that inhibits VEGFR1, VEGFR2, and VEGFR3 (IC50=34/13/13 nM), FGFR1, FGFR2, and FGFR3 (IC50=69/37/Formule :C31H33N5O4Degré de pureté :98% - 99.92%Couleur et forme :SolidMasse moléculaire :539.62LY2874455
CAS :LY2874455 has been used in trials studying the treatment of Advanced Cancer.Formule :C21H19Cl2N5O2Degré de pureté :97.22% - 99.46%Couleur et forme :SolidMasse moléculaire :444.31Ref: TM-T2361
1mg52,00€5mg97,00€10mg160,00€25mg313,00€50mg494,00€100mg742,00€200mg1.008,00€1mL*10mM (DMSO)111,00€U3-1784
U3-1784 is a humanized monoclonal antibody targeting CD334, with anti-cancer activity, used in liver cancer research.Couleur et forme :LiquidMasse moléculaire :145.5AZ8010
CAS :AZ8010 (AZ12908010) serves as an effective inhibitor of FGFR1-3 and exhibits antiproliferative properties, making it useful for cancer research.Formule :C27H34N4O3Couleur et forme :SolidMasse moléculaire :462.58S49076
CAS :S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3, blocking cellular phosphorylation of MET, AXL, and FGFRs.Formule :C22H22N4O4SDegré de pureté :95.35% - 97.4%Couleur et forme :SolidMasse moléculaire :438.5Ref: TM-T3274
1mg47,00€2mg63,00€5mg84,00€10mg96,00€25mg170,00€50mg305,00€100mg558,00€1mL*10mM (DMSO)92,00€Efimosfermin alfa
Efimosfermin alfa is a humanized antibody targeting FGFR1.Couleur et forme :Odour LiquidASP5878
CAS :ASP5878 potently inhibited the tyrosine kinase activities of recombinant FGFR1, 2, 3, and 4 with IC50 values of 0.47, 0.60, 0.74, and 3.5 nmol/L.Formule :C18H19F2N5O4Degré de pureté :99.8% - 99.86%Couleur et forme :SolidMasse moléculaire :407.37Masitinib
CAS :Masitinib (AB1010) is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs.Formule :C28H30N6OSDegré de pureté :100% - 99.55%Couleur et forme :SolidMasse moléculaire :498.64Ponatinib
CAS :Ponatinib (AP24534) is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5/2.2/5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectivelyFormule :C29H27F3N6ODegré de pureté :98% - 99.60%Couleur et forme :SolidMasse moléculaire :532.56NSC 12
CAS :NSC 12 is an orally active pan-FGF trap that binds FGF2 and interferes with its interaction with FGFR1 with potential FGF-dependent antitumor activity.Formule :C24H34F6O3Degré de pureté :99.51%Couleur et forme :SolidMasse moléculaire :484.52Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD
CAS :Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and is an FGF21-receptor agonist.Formule :C26H32N4O8Degré de pureté :100% - 99.83%Couleur et forme :SolidMasse moléculaire :528.55SUN11602
CAS :SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.Formule :C26H37N5O2Degré de pureté :98.43%Couleur et forme :SolidMasse moléculaire :451.6Lenvatinib
CAS :Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, and RET, and has oral activity.Formule :C21H19ClN4O4Degré de pureté :98.46% - 99.8000%Couleur et forme :SolidMasse moléculaire :426.85ON123300
CAS :ON123300 is a potent and multi-targeted kinase inhibitor for CDK4/Ark5/PDGFRβ/FGFR1/RET/Fyn (IC50: 3.9/5/26/26/9.2/11 nM).Formule :C24H27N7ODegré de pureté :99.22% - 99.53%Couleur et forme :SolidMasse moléculaire :429.52Derazantinib
CAS :Derazantinib (ARQ-087) is a potent, ATP-competitive, orally active tyrosine kinase inhibitor.Cost-effective and quality-assured.Formule :C29H29FN4ODegré de pureté :99.71%Couleur et forme :SolidMasse moléculaire :468.57Ref: TM-TQ0228
1mg52,00€5mg116,00€10mg169,00€25mg271,00€50mg401,00€100mg597,00€200mg850,00€1mL*10mM (DMSO)125,00€Irpagratinib
CAS :Irpagratinib (ABSK011) is an FGFR4 antagonist with anticancer activity, inhibiting FGFR4 autophosphorylation and blocking downstream signaling pathways.Formule :C28H32F2N6O5Degré de pureté :99.08%Couleur et forme :SolidMasse moléculaire :570.59Ref: TM-T79850
1mg98,00€5mg232,00€10mg373,00€25mg737,00€50mg1.175,00€100mg1.824,00€200mg2.441,00€1mL*10mM (DMSO)291,00€Fisogatinib
CAS :Fisogatinib (BLU-554) is a highly potent, selective, and orally active FGFR4 inhibitor.Cost-effective and quality-assured.Formule :C24H24Cl2N4O4Degré de pureté :99.27% - ≥95%Couleur et forme :SolidMasse moléculaire :503.38Ref: TM-T3456
1mg52,00€5mg120,00€10mg177,00€25mg310,00€50mg469,00€100mg707,00€500mg1.415,00€1mL*10mM (DMSO)134,00€Sucralfate
CAS :Sucralfate (Sucrose octasulfate-aluminum complex) is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of activeFormule :C12H54Al16O75S8Degré de pureté :98%Couleur et forme :White Amorphous PowderMasse moléculaire :2086.75SM27
CAS :SM27 is a fibroblast growth factor 2 (FGF2) inhibitor with anti-angiogenic activity and can be used to study tumours.Formule :C21H16N2O9S2Degré de pureté :98.83%Couleur et forme :SolidMasse moléculaire :504.49TG 100572 Hydrochloride
CAS :TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases(IC50s of 2, 7, 2, 16, 13, 5, 0.5, 6, 0.Formule :C26H27Cl2N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :512.43H3B-6527
CAS :H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma, with antineoplastic activity.Formule :C29H34Cl2N8O4Degré de pureté :97.45%Couleur et forme :SolidMasse moléculaire :629.54Ref: TM-T7738
1mg70,00€5mg169,00€10mg274,00€25mg530,00€50mg748,00€100mg1.064,00€1mL*10mM (DMSO)283,00€ODM-203
CAS :ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor ImmunityFormule :C26H21F2N5O2SDegré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :505.54FIIN-4
CAS :FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.Formule :C35H38N8O4Degré de pureté :100%Couleur et forme :SolidMasse moléculaire :634.73GW786034B
CAS :Pazopanib HCl (Votrient) inhibits VEGFR1-3, PDGFR, FGFR, c-Kit, c-Fms with IC50 range 10-146 nM in cell-free assays.Formule :C21H23N7O2S·HClDegré de pureté :99.87%Couleur et forme :SolidMasse moléculaire :473.98Ref: TM-T6930
10mg52,00€25mg90,00€50mg96,00€100mg140,00€200mg229,00€500mg359,00€1mL*10mM (DMSO)52,00€Regorafenib
CAS :Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor that inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and PDGFRβ and is orallyFormule :C21H15ClF4N4O3Degré de pureté :98% - 99.95%Couleur et forme :SolidMasse moléculaire :482.82Ref: TM-T1792
5mg35,00€10mg51,00€25mg80,00€50mg96,00€100mg144,00€200mg185,00€500mg309,00€1mL*10mM (DMSO)57,00€Danusertib
CAS :Danusertib (PHA-739358) is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity.Formule :C26H30N6O3Degré de pureté :97.88% - 98.44%Couleur et forme :White PowderMasse moléculaire :474.55Ref: TM-T2094
1mg59,00€2mg85,00€5mg116,00€10mg188,00€25mg365,00€50mg555,00€100mg795,00€500mg1.605,00€1mL*10mM (DMSO)120,00€FGFR1 inhibitor-17
CAS :FGFR1inhibitor-17 (Compound 92) is a potent inhibitor of FGFR1, with promising applications in cancer research.Formule :C16H13ClN2O3Couleur et forme :SolidMasse moléculaire :316.739ENMD-2076
CAS :ENMD-2076, a multi-targeted kinase inhibitor, has specific activity against Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRα.Formule :C21H25N7Degré de pureté :97.63% - ≥95%Couleur et forme :SolidMasse moléculaire :375.47Ref: TM-T2358
1mg51,00€2mg72,00€5mg105,00€10mg159,00€25mg279,00€50mg462,00€100mg648,00€1mL*10mM (DMSO)116,00€2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS :Formule :C21H15ClF4N4O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :482.8154Ref: IN-DA00ICN3
1g131,00€5g255,00€10g619,00€25gÀ demander10mg30,00€50mg46,00€100mg56,00€250mg69,00€500mg100,00€PROTAC FGFR1 degrader-1
PROTAC FGFR1 degrader-1 (compound S2H) is a targeted degrader of FGFR1, demonstrating an IC50 of 26.81 nM and a DC50 of 39.78 nM in KG1a cells. This compound is composed of a CRBN-type E3 ligase ligand (blue part) Pomalidomide, a target protein ligand (red part) FGFR1ligand-1, and a PROTAC linker (black part) 9-Bromononanoic acid, together forming the conjugate E3LigaseLigand-linker Conjugate 164.Formule :C46H54N8O8Couleur et forme :SolidMasse moléculaire :846.97Surfen dihydrochloride
CAS :Surfen dihydrochloride (Aminoquinuride dihydrochloride) is a heparin sulfate antagonist with antimicrobial properties and inhibits blockade of signaling.Formule :C21H22Cl2N6ODegré de pureté :97.08%Couleur et forme :SolidMasse moléculaire :445.35PD-089828
CAS :PD 089828 inhibits FGFR1, PDGFRβ, EGFR (IC50s: 0.15-5.47 μM), and c-Src (IC50: 0.18 μM).Formule :C18H18Cl2N6ODegré de pureté :96.78%Couleur et forme :SolidMasse moléculaire :405.28Fanregratinib
CAS :Fanregratinib is a fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor.Formule :C27H33ClN6O2Couleur et forme :SolidMasse moléculaire :509.04FGFR4-IN-14
FGFR4-IN-14 (Compound 27i) is a selective FGFR4 inhibitor with an IC50 of 2.4 nM, showing potent inhibition of cell proliferation in the V550L and N535K mutantFormule :C27H25Cl2N5O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :522.43FGFR-IN-16
CAS :FGFR-IN-16 (compound 7N) is a potent inhibitor of FGFR1, FGFR2, and FGFR4, exhibiting IC50 values of 8 nM, 4 nM, and 3.8 nM respectively. It plays a crucial role in cancer research.Formule :C30H27Cl2N7O4Couleur et forme :SolidMasse moléculaire :620.49Masitinib mesylate
CAS :Masitinib mesylate (AB-1010 mesylate) is a selective and orally bioavailable c-Kit inhibitor (IC50 of 200 nM,540/800 nM,510 nM for human recombinant c-Kit;Formule :C29H34N6O4S2Degré de pureté :100% - 97.67%Couleur et forme :SolidMasse moléculaire :594.75Ref: TM-T8544
5mg35,00€10mg51,00€25mg77,00€50mg95,00€100mg144,00€200mg225,00€500mg373,00€1mL*10mM (DMSO)49,00€SSR128129E free acid
CAS :SSR128129E free acid is an orally available and allosteric inhibitor of FGFR(IC50 of 1.9 μM for FGFR1).Formule :C18H16N2O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :324.33Bemarituzumab
CAS :Bemarituzumab: humanized IgG1 antibody inhibits FGFR2b, may be used in cancer research.Degré de pureté :SDS-PAGE:95% SEC-HPLC:99.99%Couleur et forme :LiquidMasse moléculaire :144 kDaFGFR2-IN-2
CAS :FGFR2-IN-2 is a specific FGFR2 inhibitor that inhibits FGFR1, FGFR2, and FGFR3, and can be used in the study of cancer and cardiovascular disease.Formule :C23H22N4ODegré de pureté :98.09%Couleur et forme :SolidMasse moléculaire :370.45PHA-680632
CAS :PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively.Formule :C28H35N7O2Degré de pureté :98.20%Couleur et forme :SolidMasse moléculaire :501.62PD173074
CAS :PD173074 inhibits FGFR1 (IC50: 25 nM) and VEGFR2 (100-200 nM); ~1000x more selective for FGFR1 over PDGFR/c-Src.Formule :C28H41N7O3Degré de pureté :98.15% - 98.21%Couleur et forme :Yellow SolidMasse moléculaire :523.67Ref: TM-T2642
5mg43,00€10mg57,00€25mg89,00€50mg140,00€100mg221,00€200mg393,00€500mg655,00€1mL*10mM (DMSO)59,00€Ferulic acid sodium
CAS :Ferulic acid sodium (Sodium ferulic) is an agent used in the treatment of cardiovascular and cerebrovascular diseases and to prevent thrombosis.Formule :C10H9NaO4Degré de pureté :99.58%Couleur et forme :White Crystalline PowderMasse moléculaire :216.16FGFR4-IN-1
CAS :FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).Formule :C24H27N7O5Degré de pureté :98.96%Couleur et forme :SolidMasse moléculaire :493.52
![2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluoroph…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00ICN3.webp&w=3840&q=75)
